Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CeQur Simplicity is a wearable, discreet, bolus-only insulin delivery patch designed for people with diabetes who require mealtime insulin. It is a simple, mechanical device that contains no electronics or batteries and is worn on the body for up to three days. Each manual squeeze of the device's side buttons delivers 2 units of rapid-acting insulin subcutaneously. The patch is intended to replace multiple daily injections (MDI) for bolus dosing, aiming to improve patient adherence and glycemic control. Clinical data have demonstrated that initiation of the CeQur Simplicity patch is associated with significant reductions in HbA1c and improvements in time-in-range (TIR) without increasing the risk of hypoglycemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CeQur Simplicity.